
- 1D
- 1W
- 1M
- 1Y
- 5Y
- YTD
About LIANBIO
Lianbio is a China-based company engaged in the research and development (R&D) and commercialization of innovative drugs. The Company has established production lines for nine candidate products, including Mavacamten, TP-03, NBTXR3, Infigratinib, BBP-398, Omilancor, NX13, LYR210, Sisunatovir. The Company's products cover five different treatment areas, including cardiovascular, cancer, ophthalmology, inflammatory diseases and respiratory indications.
Stock Analysis
